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Tuesday, August 23, 2022
As the COVID-19 pandemic continues to evolve, we are seeing other emerging public health
threats/emergencies and we continue to address ongoing/emerging disaster issues, the Center for
Disaster Medicine has been and will continue to be a source of reliable information, education and
models for mitigation, preparedness, response, and recovery. As such we have expanded this
informational document to address the broader areas addressed by the center while retaining critical
COVID19 information. As the pace of new information and changes occur, we will evaluate the
current once per week to determine if this information should be provided on a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics

Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

596,863,264

6,455,565

12,079,233,180

United States

93,623,973

1,040,898

603,332,091

New Jersey

2,656,736

34,467

18,041,282

New York

5,947,458

70,882

40,907,321

Connecticut

869,372

11,180

8,011,088

Information as of 8/23/22 at 0800 EDT. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
•
•
•
•

Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continue to partner with local organizations such as Westchester Department of Emergency
Services and Westchester Medical Center to ensure ongoing collaboration with all public
safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.

•
•
•
•
•

Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.
On August 18, 2022, Assistant Director of the Center for Disaster Medicine George W.
Contreras conducted an interview and demonstration during a live segment of Despierta
America for Univision 41. Despierta America is the Spanish equivalent of Good Morning
America. He discussed the importance of raising awareness regarding life-threatening
bleeding using STOP THE BLEED training for the Spanish speaking public.

The White House
On August 18, 2022, the White House Monkeypox Response Team and Public Health Officials
provided a press briefing regarding monkeypox. Bob Fenton, the White House Monkeypox
Response Coordinator, Secretary Becerra, Assistant Secretary O’Connell, and Dr. Walensky
and provided a brief update and shared some key announcements from the Biden
administration’s whole-of-government response to the monkeypox outbreak.
https://www.whitehouse.gov/briefing-room/speeches-remarks/2022/08/18/press-briefing-bywhite-house-monkeypox-response-team-and-public-health-officials-2/
On August 18, 2022, the White House National Monkeypox Response team announced a series
of actions the Biden-Harris Administration is taking to further accelerate its response to the
monkeypox (MPV) outbreak and mitigate the spread of the virus. Since the first case was
confirmed in the United States, the Administration has led a whole-of-government response to
make tests, vaccines, and treatments more widely available to communities across the country
and has worked with the LGBTQI+ community to provide information and resources directly to
communities most at risk of contracting the virus.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/08/18/fact-sheet-whitehouse-announces-new-actions-to-combat-monkeypox-outbreak/
On August 16, 2022, the Biden Administration laid out key supports and guidance for protecting
students, teachers, and school communities this upcoming school year, and managing and
mitigating the risks of COVID-19 spread. This includes making an abundance of federal
resources available to schools to implement these strategies. Because of the investments the
Administration has made — including $122 billion in American Rescue Plan funding to keep
schools open safely, combat learning loss, and address student mental health — and because of
the tools we now have in place, we can prevent school closures, even as COVID-19 cases in a
community fluctuate.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/08/16/fact-sheet-back-toschool-2022-giving-every-school-the-tools-to-prevent-covid-19-spread-and-stay-safely-open-allyear-long/
The official website of the White House delivers updated information as the country grapples
with converging crises. This will include actions to control current public health threats, provide
economic relief, tackle climate change, and advance racial equity and civil rights, as well as
immediate actions to reform our immigration system and restore America’s standing in the world.
This website will provide all information in one central location. https://www.whitehouse.gov
COVID-19 Website
On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website
was launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/
Health and Human Services (HHS)

On August 18, 2022, HHS Facilitated Agreement to Accelerate Delivery of Additional Smallpox
and Monkeypox Vaccines Using New U.S. Production Line- The U.S. Department of Health and
Human Services (HHS) has facilitated an agreement between Bavarian Nordic and Grand River
Aseptic Manufacturing (GRAM), a Michigan-based pharmaceutical contract manufacturer, to
establish the first fill and finish line for the JYNNEOS vaccine in the U.S. To support the current
monkeypox outbreak and future smallpox preparedness, the Biomedical Advance Research and
Development Authority (BARDA), within the HHS Administration for Strategic Preparedness and
Response (ASPR), has ordered 5.5 million vials of JYNNEOS from Bavarian Nordic to be filled,
finished and delivered from U.S. government-owned bulk vaccine stored in Denmark. Under the
procurement, Bavarian Nordic agreed to complete a technology transfer that would allow for 2.5
million of those vials to be filled and finished by a U.S.-based contract manufacturer.
https://www.hhs.gov/about/news/2022/08/18/hhs-facilitates-agreement-accelerate-deliveryadditional-smallpox-monkeypox-vaccines-using-new-us-production-line.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html
National Institutes of Health (NIH)
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
As of August 19, 2022, 439 tests and sample collection devices are authorized by the
FDA under emergency use authorizations (EUAs). These include 302 molecular tests and
sample collection devices, 85 antibody and other immune response tests, 51 antigen
tests, and 1 diagnostic breath test. There are 78 molecular authorizations and 1 antibody
authorization that can be used with home-collected samples. There is 1 EUA for a
molecular prescription at-home test, 2 EUAs for antigen prescription at-home tests, 19
EUAs for antigen over-the-counter (OTC) at-home tests, and 3 for molecular OTC athome tests. The FDA has authorized 31 antigen tests and 8 molecular tests for serial
screening programs. The FDA has also authorized 1089 revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-august-19-2022

On August 19, 2022, the FDA authorized the emergency use of Novavax COVID-19
Vaccine, Adjuvanted for the prevention of Coronavirus Disease 2019 (COVID-19) caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12
through 17 years of age. This authorization follows a rigorous analysis and evaluation of
the safety and effectiveness data conducted by the FDA.
https://www.fda.gov/news-events/press-announcements/fda-roundup-august-19-2022
On August 18, 2022, the FDA issued the report: “FDA’s Work to Combat the COVID-19
Pandemic,” which outlines much of the broad range of work the FDA is undertaking to
combat the COVID-19 pandemic and prepare for future emergencies. The FDA continues
to build on the foundation of scientific rigor, thoughtfulness, and adaptability in rising to
this challenge.
https://www.fda.gov/media/160998/download
The FDA created a specific monkeypox response page which serves as a central source
of information regarding diagnostics, vaccines, and therapeutics. For the latest FDA
information regarding monkeypox, please visit
https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/fdamonkeypox-response
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19
Centers for Disease Control and Prevention (CDC)
Monkeypox is a rare disease caused by infection with the monkeypox virus. Monkeypox
virus is part of the same family of viruses as variola virus, the virus that causes smallpox.
Monkeypox symptoms are like smallpox symptoms, but milder, and monkeypox is rarely
fatal. Monkeypox is not related to chickenpox.
For the latest CDC information including symptoms, testing, vaccines and prevention
regarding monkeypox, please visit
https://www.cdc.gov/poxvirus/monkeypox/
According to the CDC, as of August 22, 2022, there are 15,433 cases in the United
States. For the latest monkeypox cases in the United States, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html
According to the CDC, as of August 22, 2022, there are 42,954 cases in the world. For
the latest global monkeypox cases, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
On August 22, 2022, the CDC provided an updated report on the impact of Monkeypox
Outbreak on Select Behaviors. In an online survey of gay, bisexual, and other men who
have sex with men conducted during August 5-15, 2022, respondents reported changing
their behavior because of the monkeypox outbreak: 48 percent reported reducing their
number of sex partners, 50 percent reported reducing one-time sexual encounters, and
49 percent reported reducing sex with partners met on dating apps or at sex venues.

https://www.cdc.gov/poxvirus/monkeypox/response/2022/amis-select-behaviors.html
As of August 22, 2022, the CDC updated its monkeypox Frequently Asked Questions
(FAQs) covering signs and symptoms, prevention, vaccines, treatment and spread.
https://www.cdc.gov/poxvirus/monkeypox/faq.html
As of August 19, 2022, the CDC updated the monkeypox section regarding the latest
information on signs and symptoms, vaccines, prevention, sexual health, cases and data.
https://www.cdc.gov/poxvirus/monkeypox/index.html
On August 22, 2022, CDC Director Rochelle P. Walensky, M.D., M.P.H., signed a
decision memo that Novavax’s COVID-19 vaccine be used as another primary series
option for adolescents ages 12 through 17. This recommendation follows FDA’s
authorization to authorize the vaccine for this age group under emergency use. Novavax’s
COVID-19 vaccine, which is available now, is an important tool in the pandemic and
provides a more familiar type of COVID-19 vaccine technology for adolescents. Having
multiple types of vaccines offers more options and flexibility for the public, jurisdictions,
and vaccine providers.
https://www.cdc.gov/media/releases/2022/s0822-novax-vaccine.html
On August 22, 2022, the CDC provided updated guidance regarding what to Know About
COVID-19 Testing in Schools
https://www.cdc.gov/media/releases/2022/s0822-novax-vaccine.html
On August 22, 2022, the CDC provided updated information regarding health equity and
promoting fair access to health.
https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/index.html
CDC provides updated information about the variants in the United States- The emerging
variants CDC is closely monitoring have mutations in the virus genome that alter the
characteristics and cause the virus to act differently in ways that are significant to public
health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 p.m. ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html
Center for Medicare and Medicaid Services (CMS) +
View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of July 19, 2022, the FDA has granted Emergency Use
Authorization (EUA) to Janssen/Johnson & Johnson for adults over 18 years and
Novavax for adults over 18 years of age and EUA for Moderna and Pfizer for children 6
months to five years. On August 19, 2022, the FDA authorized the emergency use of
Novavax COVID-19 Vaccine, Adjuvanted for the prevention of Coronavirus Disease 2019
(COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in individuals 12 through 17 years of age. This authorization follows a rigorous analysis
and evaluation of the safety and effectiveness data conducted by the FDA. On August 23,
2021, the FDA granted full approval to Pfizer for adults. On January 31, 2022, the FDA
granted full approval to Moderna for adults. Now with two vaccines with full FDA approval
and three vaccines with EUA for adults and children, the goal is to vaccinate a larger
number of persons in the coming months throughout the United States. As additional
vaccines are granted EUA, information for those vaccines will also be included.
CDC created this section regarding COVID-19 vaccinations in the United States- CDC
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 p.m. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
The NYS DOH provides updated monkeypox information regarding signs and symptoms,
cases, vaccine, treatment and prevention at
https://health.ny.gov/diseases/communicable/zoonoses/monkeypox/
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works. As of January 31, 2022, the fully FDA
approved Moderna vaccine will now be known as SPIKEVAX for ages six months and
older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully

FDA approved Pfizer vaccine will now be known as COMIRNATY for ages six months and
older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/
Educational Institution Information
•

•

Higher Education
• A group of public health experts wants the American Public Health
Association to replace Dr. Leana Wen as a panelist at the APHA’s annual
meeting in November in Boston. Dr. Wen, research professor of health
policy and management at George Washington University, previously
served as the health commissioner for the city of Baltimore and the
president of Planned Parenthood. She’s scheduled to speak to APHA
members about “backlash” against public health during a panel on this
theme. And she knows quite a bit about backlash: Dr. Wen, a frequent
media commentator on COVID-19, has faced death threats and
harassment over her thoughts on masking, vaccination and more; earlier
this year, a Texas man pleaded guilty to threatening to shoot Dr. Wen
following a federal investigation into this threat. Read more at:
https://www.insidehighered.com/news/2022/08/05/colleges-preparepotential-monkeypox-outbreaks
K-12
• August 22, 2022- Five strategies for rebuilding student engagement after
COVID-19. The former superintendent of Pittsburgh Public Schools writes
that reconnecting with students requires multiple strategies, open
dialogue, trust and empathy. There’s no single answer. Demonstrating
our commitment to students will take multiple forms and require open
dialogue, trust and empathy. In this article are a few practices for
teachers and administrators to consider. Read more regarding strategies
for student engagement after COVID-19 at
https://www.k12dive.com/news/5-strategies-for-rebuilding-studentengagement-after-covid-19/630143/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=
American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates

New York
• On August 17, 2022, Governor Hochul announced the re-launch of #VaxtoSchool, the
multi-faceted statewide campaign aimed at increasing COVID-19 vaccination rates
among school-aged New Yorkers. The campaign furthers Governor Hochul's
commitment to ensuring equitable access to vaccines, and to make the health and wellbeing of students, teachers and families a top priority. "As we prepare for the beginning
of the school year and the fall season, it is important that we do all we can to protect our
youngest New Yorkers," Governor Hochul said. "By breaking down barriers to vaccine
access, these partnerships will allow New York State to continue to protect the health
and safety of our most vulnerable community members and keep our schools open. The
re-launching of our successful #VaxtoSchool campaign will support our Fall Action Plan,
and ensure we are getting New Yorkers the resources they need to protect themselves
from being seriously ill or hospitalized due to COVID-19."
https://www.governor.ny.gov/news/governor-hochul-announces-re-launch-vaxtoschoolcovid-19-vaccine-effort
New York State Department of Health (DOH)
On August 22, 2022, Governor Hochul updated New Yorkers on the state's progress combating
COVID-19. She announced updated COVID-19 guidance that aligns with new CDC
recommendations as children, teachers and faculty across the state prepare to head back to
school in the coming weeks. Among other recommendations, this new guidance specifies that
asymptomatic school children exposed to COVID-19 no longer need to quarantine and that
isolation is now only advised for individuals who have tested positive for the virus. "As we
continue to monitor the current numbers, I encourage all New Yorkers to keep using the tools we
know that work to protect against COVID-19," Governor Hochul said. "Please get vaccinated or
boosted when you're eligible or if you haven't already. Test if you have symptoms, and if you're
positive stay home and talk to you doctor at treatment. By remaining vigilant and responsible,
New Yorkers will continue to work together to beat this virus."
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progresscombating-covid-19-326
On August 22, 2022, Governor Hochul announced up to $20 million is available to support
addiction services providers in New York State that have been impacted by the ongoing effects
of the COVID-19 pandemic. Administered by the New York State Office of Addiction Services
and Supports, the federal funding will assist providers with fiscal recovery and enable them to
continue offering COVID-safe substance use disorder prevention, treatment, harm reduction,
and recovery services. "New Yorkers continue to feel the effects of the COVID-19 pandemic in
all aspects of daily life, including addiction treatment," Governor Hochul said. "Like far too many
New Yorkers, my family has lost a loved one battling with addiction, and this funding will be
integral in helping treatment providers continue their crucial work. My administration will continue
our work to support providers to help New Yorkers who need it most."
https://www.governor.ny.gov/news/governor-hochul-announces-20-million-addiction-servicesproviders-impacted-covid-19-pandemic
For a list of COVID-19 positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n

NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey
• On August 22, 2022, NJOHSP Adds Monkeypox (hMPXV) Update to Disinformation
Page- The New Jersey Office of Homeland Security and Preparedness updated its
disinformation portal web page last week to incorporate monkeypox (hMPXV)
disinformation trends circulating on the internet. According to a recent intelligence review
conducted by NJOHSP’s Analysis Bureau, false information on monkeypox (hMPXV) is
spreading online and sparking new confusion about the virus among the public.
Misleading videos, falsely attributed information and the recycling of COVID-19
conspiracies are some of the methods causing dissent. “As we see an attempt to sow
discord in New Jersey and throughout our country through the spread of disinformation,
it is critical that we communicate accurate information to the public, especially as it
relates to the monkeypox virus,” said Governor Phil Murphy. “My administration remains
committed to a comprehensive response that prioritizes the health and safety of our

communities. I urge New Jersey residents to utilize State resources for information
about symptoms, risks and availability of both testing and vaccines.”
https://www.state.nj.us/governor/news/news/562022/approved/20220822a.shtml
•

On August 18, 2022, Governor Murphy, Acting AG Platkin Announce Publication of
Division on Civil Rights FAQs to Prevent Discrimination Related to hMPXV
(“Monkeypox”)- Governor Murphy and Acting Attorney General Matthew J. Platkin
announced today that the Division on Civil Rights (DCR) within the Attorney General’s
Office published FAQs for the public about New Jersey residents’ rights and protections
against discrimination and bias-based harassment related to the “monkeypox” virus, as
well as information about how to file a civil rights complaint with DCR if members of the
public are victims of discrimination. The FAQs issued address frequently asked
questions about discrimination and harassment related to human hMPXV, commonly
known as the “monkeypox” virus, and the protections that New Jersey’s Law Against
Discrimination (LAD) affords to those infected with hMPXV.
https://www.state.nj.us/governor/news/news/562022/approved/20220818b.shtml

Connecticut
• On August 19, 2022, Governor Lamont Announced 15,000 Low-Income Households
With Children Will Receive a Back-to-School, COVID-19 Relief Special Benefit on
Sunday- Governor Lamont announced that the Connecticut Department of Social
Services this weekend will deliver a one-time, back-to-school, COVID-19 relief special
benefit of $257.87 per child to more than 15,000 low-income Connecticut households on
behalf of 27,000 children. Known as the Pandemic Emergency Assistance Fund (PEAF),
this special benefit comes from a $7 million federal grant the Connecticut Department of
Social Services received from the Administration for Children and Families, a division of
the U.S. Department of Health and Human Services, through the American Rescue Plan
Act.
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/082022/Governor-Lamont-Announces-15000-Low-income-Households-Will-Receive-aBack-to-School-Special-Benefit
• On August 18, 2022, Governor Lamont Provided Update on Connecticut’s Coronavirus
Response Efforts- Governor Lamont provided the latest information regarding COVID-19
response and data. The Connecticut Department of Public Health reported that as of
August 17, 2022, a total of 266,930 cases of COVID-19 among fully vaccinated persons
in Connecticut have been identified. Those cases account for 9.72 percent of the more
than 2.7 million people in the state who are fully vaccinated.
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/082022/Governor-Lamont-Coronavirus-Update-August-18
• On August 16, 2022, Governor Lamont Announced Commencement of CareerConneCT,
a Holistic Approach To Help Workers Impacted by COVID-19 Through Job Training
Programs- Governor Ned Lamont today announced the commencement of 19 job
training programs funded by CareerConneCT, a $70 million program designed to
support getting individuals in Connecticut whose employment has been impacted by
COVID-19 back to work. These statewide and regional programs will provide short-term
job training through industry-recognized credentials that create pathways to employment
in high-quality, in-demand careers.https://portal.ct.gov/Office-of-theGovernor/News/Press-Releases/2022/08-2022/Governor-Lamont-AnnouncesCommencement-of-CareerConneCT

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
New York City is currently the epicenter of the monkeypox outbreak in the United States. As of
August 22, 2022, there are 2, 964 cases of monkeypox in New York City. For the latest information
including cases, symptoms, testing and vaccine information regarding monkeypox in New York City,
please visit
https://www1.nyc.gov/site/doh/health/health-topics/monkeypox.page
NYC DOHMH launched a new COVID-19 variants data page. The data on this page show how
variants of the virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus
with certain sets of mutations. Some variants may result in a COVID-19 infection that is easier to
spread, more severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page

https://www1.nyc.gov/site/doh/covid/covid-19-data.page
Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of August 21, 2022
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including vaccines for children.
https://health.westchestergov.com/2019-novel-coronavirus
As of August 22, 2022, Westchester County has 75 cases of monkeypox.
Monkeypox Vaccine Clinics on Mondays and Wednesdays at 134 Court Street, White Plains.
Appointments are required. People at higher risk for monkeypox infection may consider vaccination
with the two-dose JYNNEOS vaccine. In accordance with CDC guidance, this includes those who:
•
•
•

Had contact with someone who had a rash that looks like monkeypox or with someone who
was diagnosed with confirmed or probable monkeypox
Had skin-to-skin contact with someone in a social network experiencing monkeypox activity;
this includes men who have sex with men who meet partners through an online website,
digital application (“app”), or social event such as at a bar or party
Traveled outside the United States to a country with confirmed cases of monkeypox or
where monkeypox activity has been ongoing

Monkeypox Vaccine appointments are also available at:
- Westchester Medical Center, 15 Oval Connector, Valhalla, NY 10595
Monday through Friday from 9 a.m. - 5 p.m., appointment required.
Call (914) 326-2060 to schedule an appointment.
For more information regarding monkeypox in Westchester County, please visit
https://health.westchestergov.com/
Putnam County Department of Health
Breakdown of COVID -19 positive cases by towns in Putnam County as of August 19, 2022.
https://www.putnamcountyny.com/covid19/
As of August 22, 2022, there are 2 cases of monkeypox in Putnam County.
As of August 11, 2022, Putnam has not been allocated any JYNNEOS vaccine from New York State,
however Putnam residents who are considered at-risk for monkeypox are eligible for vaccination at
sites nearby in Westchester County. If any eligible resident encounters difficulty acquiring a
monkeypox vaccine appointment, they should call the Putnam County Department of Health at 845808-1390.”
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/
Dutchess County Department of Health

Breakdown of positive cases in Dutchess County as of August 19, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
As of August 22, 2022, there are 8 cases of monkeypox in Dutchess County. For the latest
information regarding monkeypox, please visit
https://www.dutchessny.gov/Departments/DBCH/dbch.htm
Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of August 18, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
As of August 22, 2022, there are 8 cases of monkeypox in Orange County. For more information
regarding monkeypox, please visit
https://www.orangecountygov.com/149/Health
Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
August 15, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
As of August 22, 2022, there is 7 cases of monkeypox in Rockland County.
For more information regarding monkeypox, please visit Rockland County Health Department
website
https://rocklandgov.com/departments/health/
Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

Faculty News:
Regular Exercise Can Help Shield You From Severe COVID
U.S. News and World Report
8/23/2022
https://www.usnews.com/news/health-news/articles/2022-08-23/regular-exercise-can-helpshield-you-from-severe-covid
Armeen D. Poor, M.D., clinical assistant professor of medicine
NYMC Leadership News:
Do we have to worry again about polio? Health officials in London are concerned (at
10:28 mark)
KNX Indepth
8/11/2022
https://podcasts.apple.com/us/podcast/knx-in-depth-former-president-trump-takes-the-5thin/id1423814166?i=1000575705785
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president of government affairs
Can You Get Monkeypox From Something You Touched?
Verywell Health
8/18/2022
https://www.verywellhealth.com/can-you-contract-monkeypox-from-surfaces-6499690
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president of government affairs

Every effort is made to provide accurate and complete information in this newsletter.
However, New York Medical College cannot guarantee that there will be no errors. NYMC
makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of
the contents of the newsletters or the articles linked herein and further expressly disclaims
liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice.
Always seek the advice of your physician or other qualified health provider with any questions
you may have regarding a medical condition.
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